Search

everythinglearnresearchcommunity

for

Search:↓

The ginseng cicada decoction effectively reduces atopic dermatitis symptoms and improves quality of life safely.

Combination 3 of ethnomedicinal plants from Nusa Tenggara Timur significantly increases hair-follicle thickness.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Blocking CXXC5 speeds up diabetic wound healing by improving blood vessel growth and skin repair.

Giant pituitary macroadenomas causing Cushing disease are rare and may need extra treatment if surgery fails.

Finasteride helps female-pattern hair loss.

Topical cetirizine 1% promotes hair growth in male androgenetic alopecia patients.

Soymetide-4 from soy can prevent hair loss caused by a cancer drug in rats.

Pemetrexed with cisplatin is safer and more effective than gemcitabine with cisplatin for advanced lung cancer.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Intralesional cidofovir might be a good alternative treatment.

The research found a way to develop hair growth materials by targeting a specific signaling pathway.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Epidermal growth factor helps hair recover after chemotherapy.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Tectoridin helps human hair cells grow and makes mouse hair longer, suggesting it could treat hair loss.

Baricitinib is effective and safe for treating severe alopecia areata.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.